Cargando…
Frequency of anaplastic lymphoma kinase rearrangements in Moroccan patients with non small cell lung cancer: a multi-institutional national retrospective study
BACKGROUND: Anaplastic lymphoma kinase (ALK) rearrangement is a predictive factor of response to ALK inhibitors in non small cell lung cancer (NSCLC). The prevalence of ALK rearrangements is well known in Whites and Asians. However, data identifying the frequency of this rearrangement in Moroccan an...
Autores principales: | El yacoubi, Hind, Sow, Mohamed Lemine, Kettani, Fouad, Gamra, Lamia, Mestari, Amina, Jabri, Lamia, Elghissassi, Ibrahim, Errihani, Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251848/ https://www.ncbi.nlm.nih.gov/pubmed/32460789 http://dx.doi.org/10.1186/s12885-020-06973-4 |
Ejemplares similares
-
Frequency and Spectrum of KRAS Mutations in Moroccan Patients with Lung Adenocarcinoma
por: Elghissassi, Ibrahim, et al.
Publicado: (2014) -
Male breast cancer: a report of 127 cases at a Moroccan institution
por: Bourhafour, Mouna, et al.
Publicado: (2011) -
Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma
por: Subbiah, V., et al.
Publicado: (2021) -
Nonleukemic Granulocytic Sarcoma of Knee: A Case Report
por: Elghissassi, Ibrahim, et al.
Publicado: (2010) -
Triple negative breast cancer in Moroccan women: clinicopathological and therapeutic study at the National Institute of Oncology
por: Rais, Ghizlane, et al.
Publicado: (2012)